Piramal Pharma (BOM:543635) EV-to-Revenue : 2.99 (As of Jun. 13, 2024)

Piramal Pharma EV-to-Revenue Chart

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial							1.84	1.50	2.30	2.35	2.58

Competitive Comparison of Piramal Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's EV-to-Revenue falls into.

Piramal Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Piramal Pharma's EV-to-Revenue for today is calculated as:

Piramal Pharma's current Enterprise Value is ₹243,944 Mil.
Piramal Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹81,712 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piramal Pharma  (BOM:543635) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Piramal Pharma's PS Ratiofor today is calculated as:

Piramal Pharma's share price for today is ₹153.90.
Piramal Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹64.77.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piramal Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (BOM:543635) Business Description